Earlier this month, President Obama took the unprecedented step of authoring an academic research article in The Journal of the American Medical Association (JAMA) to document the Affordable Care Act’s (ACA) accomplishments and suggest improvements.
Market vs. Medicine goes beyond diagnosis to consider how sustaining and disruptive innovation will make U.S. healthcare better at diagnosing and treating illness while developing care management capabilities that promote prevention, behavioral health and chronic disease management. In the epic battle underway, market-driven reform, more than regulatory change, will transform and improve America’s broken healthcare system.
Many believe Big Data’s capabilities will transform healthcare and they’re probably right. Big Data’s ability to remake industries is awe-inspiring. Big Data’s enthusiasts, however, often lose sight of this basic truth: data analytics are nothing more than a performance improvement tool. All data has noise. Big Data generates sonic booms. Big Data cannot transform healthcare until health companies get “Little Data” right.
FMI’s Commentary on one cause for recent subdued retail sales: the Affordable Care Act.
In this article, David explains how asymmetric information exchange between providers and patients contributes to medical errors, customer frustration, over and under-treatment in U.S. healthcare industry.
Despite the high drama and intense media attention, Supreme Court versus Obamacare II is a sideshow. The main event remains how market forces are reshaping fundamental supply-demand relationships in healthcare delivery.
U.S. government whiffs on 10-year health expenditure forecast